Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review

por Meijboom, Rosanne W., Gardarsdottir, Helga, Egberts, Toine C. G., Giezen, Thijs J.
Publicado 2021

Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice

por Vermeer, Niels S., Giezen, Thijs J., Zastavnik, Sofia, Wolff‐Holz, Elena, Hidalgo‐Simon, Ana
Publicado 2019

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the s...

por Minnema, L. A., Giezen, T. J., Egberts, T. C. G., Leufkens, H. G. M., Gardarsdottir, H.
Publicado 2020

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars

por Alsamil, Ali M., Giezen, Thijs J., Egberts, Toine C., Leufkens, Hubert G., Gardarsdottir, Helga
Publicado 2021

Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions

por Correia Pinheiro, Luis, Giezen, Thijs J., Wolff‐Holz, Elena, Weise, Martina, Laslop, Andrea, Hidalgo‐Simon, Ana
Publicado 2021

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors

por Minnema, Lotte A., Giezen, Thijs J., Hoekman, Jarno, Egberts, Toine C.G., Leufkens, Hubert G.M., Gardarsdottir, Helga
Publicado 2020

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept

por Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., ten Wolde, Saskia, Egberts, Toine C. G., Giezen, Thijs J.
Publicado 2021

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study

por Minnema, Lotte A., Giezen, Thijs J., Souverein, Patrick C., Egberts, Toine C. G., Leufkens, Hubert G. M., Gardarsdottir, Helga
Publicado 2019

Post‐marketing dosing changes in the label of biologicals

por Minnema, Lotte A., Giezen, Thijs J., Gardarsdottir, Helga, Egberts, Toine C. G., Leufkens, Hubert G. M., Mantel‐Teeuwisse, Aukje K.
Publicado 2019

QTc Prolongation in COVID-19 Patients Using Chloroquine

por Becker, Matthijs L., Snijders, Dominic, van Gemeren, Claudia W., Kingma, Hylke Jan, van Lelyveld, Steven F. L., Giezen, Thijs J.
Publicado 2021

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar

por Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Giezen, Thijs J.
Publicado 2023

Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI

por Georgi, Benjamin, Mielke, Johanna, Chaffin, Mark, Khera, Amit V., Gelis, Lian, Mundl, Hardi, van Giezen, J.J.J., Ellinor, Patrick, Kathiresan, Sekar, Ziegelbauer, Karl, Freitag, Daniel F.
Publicado 2019

Switching TNFα inhibitors: Patterns and determinants

por Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., de Groot, Mark C. H., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Leufkens, Hubert G. M., Giezen, Thijs J.
Publicado 2021

Stabilizing Role of Platelet P2Y(12) Receptors in Shear-Dependent Thrombus Formation on Ruptured Plaques

por Nergiz-Unal, Reyhan, Cosemans, Judith M. E. M., Feijge, Marion A. H., van der Meijden, Paola E. J., Storey, Robert F., van Giezen, J. J. J., oude Egbrink, Mirjam G. A., Heemskerk, Johan W. M., Kuijpers, Marijke J. E.
Publicado 2010